Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Editorial

Promising Targets and Strategies to Control Neuroinflammation (Part I)

Author(s): Stephanie Federico and Stefano Moro

Volume 29, Issue 27, 2022

Published on: 29 June, 2022

Page: [4630 - 4630] Pages: 1

DOI: 10.2174/092986732927220629150904

conference banner
[1]
Kwon, H.S.; Kho, S-H. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl. Neurodegener., 2020, 9(1), 42.
[2]
Currais, A.; Fischer, W.; Maher, P.; Schubert, D. Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain. FASEB J., 2017, 31(1), 5-10.
[3]
Gianferrara, T.; Cescon, E.; Grieco, I. Spalluto, G. Federico, S. Glycogen synthase kinase 3β Involvement in neuroinflammation and neurodegenerative diseases. Curr. Med. Chem., 2022, 29(27), 4631-4697.
[4]
Catarzi, D.; Varano, F.; Vigiani, E. Lambertucci, C.; Spinaci, A.; Volpini, R. Colotta, V. Casein kinase 1δ inhibitors as promising therapeutic agents for neurodegenerative disorders. Curr. Med. Chem., 2022, 29(27), 4698-4737.
[5]
Marotta, G.; Basagni, F.; Rosini, M.; Minarini, A. Role of fyn kinase inhibitors in switching neuroinflammatory pathways. Curr. Med. Chem., 2022, 29(27), 4738-4755.
[6]
Pavan, M.; Bassani, D.; Bolcato, G.; Bissaro, M.; Sturlese, M.; Moro, S. Computational strategies to identify new drug candidates against neuroinflammation. Curr. Med. Chem., 2022, 29(27), 4756-4775.

© 2024 Bentham Science Publishers | Privacy Policy